Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Open in API
Filings indexed 1,872 across all filing types
Latest filing 2021-05-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
110年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items. The presence of actual financial figures and the length of the document (5043 characters) indicate it is a substantive financial report rather than a brief announcement or certification. The data corresponds to a quarterly period (first quarter of year 110 in the Taiwanese calendar, which aligns with 2021). This matches the characteristics of an Interim / Quarterly Report (IR), which includes comprehensive financial statements for a period shorter than a full fiscal year. There is no indication that this is an annual report, audit report, or other filing types. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2021
2021-05-13 Chinese
110年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for a company, with figures for the current and previous periods (first quarter of year 110 and 109 in the Taiwanese calendar). The content includes accounting items such as common stock, capital surplus, retained earnings, and other equity components. The document length is 3791 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of detailed financial tables and period-specific data indicates this is a financial report for a quarterly period rather than a mere announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-05-13 Chinese
110年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment funds remitted, shareholding percentages, and investment gains or losses. The document also references regulatory limits and approvals by the Economic Ministry Investment Commission. The content is specific to investment disclosures rather than a full financial report or earnings release. The document length is short (1291 characters) and it is a regulatory disclosure of investment information, not a full report or announcement of a report. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-05-13 Chinese
110年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not an announcement or a brief summary but a detailed disclosure of insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-05-12 Chinese
110年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It lists their current holdings, pledged shares, and related ratios. The content is focused on insider share transactions and holdings rather than financial results, management changes, or meeting materials. There is no indication of a full report or announcement of a report publication. The document is a disclosure of insider shareholdings and pledges, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is 4687 characters, which is sufficient to contain substantive data rather than a mere announcement. Therefore, the best classification is DIRS with high confidence.
2021-05-12 Chinese
110年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 台耀, providing data on fund loans and endorsement guarantees for the current and previous month, with amounts in New Taiwan Dollars. It contains tabular data but is very short (611 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of specific financial information rather than a full report or announcement of a report. There is no indication of an annual or quarterly report, audit report, or other detailed filings. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-05-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.